Clinical trial
Randomized Prospective Study of Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following Breast Conservative Surgery
NCT03710733 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Prospective Study of Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following Breast Conservative Surgery
- Lead sponsor
- National Cancer Institute, Egypt
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- June 30, 2021
- Enrollment
- 185 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
radiotherapy side effect